Sutib 25MG Capsule (7’s) is a medication that contains Sunitinib as its active ingredient, specifically formulated to target and inhibit tumor growth in various types of cancer. This oral capsule is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GISTs) that cannot be surgically removed or have metastasized. Sunitinib works by blocking specific proteins that promote cancer cell proliferation and angiogenesis, thereby reducing the tumor’s ability to grow and spread. Each capsule contains 25 mg of Sunitinib, and the formulation is designed for optimal absorption and efficacy. Patients taking Sutib can expect a comprehensive approach to managing their cancer, as it not only targets the tumor directly but also affects the surrounding blood vessels that supply nutrients to the cancer cells. This dual action makes Sutib a vital component in the oncological therapeutic arsenal.